✦ LIBER ✦

Antiparkinsonian activity of CY 208–243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's disease

✍ Scribed by J. A. Temlett; N. P. Quinn; P. G. Jenner; C. D. Marsden; E. Pourcher; A.-M. Bonnet; Y. Agid; R. Markstein; X. Lataste

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 298 KB
Volume: 4
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870040307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of a selective partil D1 agonist

Effects of a selective partil D1 agonist, CY 208-243, in de novo patients with Parkinson disease

✍ Dr. M. Emre; U. K. Rinne; A. Rascol; A. Lees; Y. Agid; X. Lataste 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB

## Abstract A selective dopamine D~1~‐receptor agonist, CY 208‐243, was administered to 23 de novo patients who had had Parkinson disease (PD) for ≤3 months. The drug was first used as monotherapy and then in some patients in combination with a dopamine D~2~‐receptor agonist, bromocriptine. Results